Cellular and molecular analysis of megakaryocytopoiesis has been hampered thus far by the lack of pure and abundant megakaryocyte (MK) cell populations. In this study. hematopoietic progenitor cells (HPCs), stringently purified from peripheral blood, were induced to megakaryocytic differentiation/maturation in serum-free liquid suspension culture treated with a growth factor cocktail (interleukin-3 [IL-3], ckit ligand, and IL-6) and/or recombinant mpl ligand (mplL).
In particular, (1) the growth factor cocktail induced the growth of a 40% MK population, ie, 4 x lo' cells at day 0 generated 2 x lo6 MK at terminal maturation; (2) further addition of mplL increased the MK purity level to 80% with a final yield of 4 x 1 0 ' MKS; (3) treatment with mplL alone resulted in a 97% to 99% MK population, with a mild increase of cell number (to 1.5 x lo6 cells). In mplL-supplemented culture, morphological evaluation indicated the presence of putative mononuclear MK precursors and then of mature polynucleated platelet-forming MKS, peaking at days 5 and 12, respectively. Membrane phenotype analysis showed a EMATOPOIESIS IS sustained by a pool of hematopoietic stem cells (HSCs) that can extensively self-renew and differentiate into hematopoietic progenitor cells (HPCs).'.' HPCs are committed to specific lineage(s) and are functionally defined as colony-forming units (CFUs) or burst-fonning units (BFUs), ie, HPCs of the erythroid series (BFU-E, CFU-E); the megakaryocytic lineage (BFU-MK, CFU-Me); the granulocyte-monocytic series (CFU-GM); and multipotent CFUs for the GM, erythroid, and megakaryocytic lineages (CFU-GEMM).'.' Early HPCs also circulate in peripheral blood (PB).
It is generally conceded that megakaryocytopoiesis involves proliferation of megakaryocytic precursors (dividing cells) and maturation of megakaryocytes (MK, nondividing cells) that increase their size by polypl~idization.~" Human hematopoietic growth factors (HGFs; termed interleukins [ILs] or colony-stimulating factors [CSFs] ) and related cytokines modulate the proliferation, self-renewal, and/or differentiation of HSCS/HPCS.~.~ HGFs exert their effect directly on HSCs/HPCs and/or indirectly on accessory cell^.^^^ Numerous cytokines and HGFs, although not specific for megakaryocytopoiesis, stimulate MK differentiation. The role played by erythropoietin (Epo) in megakaryocytopoiesis is controversial: IL-3 and granulocyte-macrophage CSF (GM-CSF) promote MK proliferation and maturation.'.' IL-6 primarily stimulates MK differentiation,'' whereas IL-11 increases the MK size and ploidy." c-kit ligand (KL) has no effect by itself but potentiates the ability of other cytokines to stimulate MK colony formation. " Two HGFs have been hypothesized to affect specifically megakaryocytopoiesis, ie, MK-CSFl3.l4 and thrombopoiematuration, respectively. c-mpl is a cytokine receptor expressed specifically in both leukemic cell lines with megakaryocytic phenotype and normal MKS.'"'' Antisense oligodeoxynucleotides targeting mpl RNA specifically inhibit CFU-MK colony formation." The murine and human mpl ligand (mplL) has been recently ~loned.'~-*~ The mplL exerts gradual decrease of CD34+ HPCs, coupled with an inverse increase of MK-spacific antigens (eg, CD61/62/42b) starting before mature MK detection by morphology analysis. In situ hybridization showed the expression of MK-specific von Willebrand gene in both MK precursors and mature MKS. Furthermore, MKS synthesize and secrete low but significant amounts of both IL-6 and granulocyte-macrophage colonystimulating factor. Comparative culture studies were performed on purified bone marrow CD34+/38h' or CD34+/38" cells stimulated by mplL alone. Both populations generated a highly enriched MK progeny (62% and 93% MKS at day 12 of culture, respectively) but showed either little or no proliferation. In conclusion, the purifiad peripheral blood HPC differentiation culture system allows for growth of a ralatively large number of highly purified or "pure" megakaryocytic precursors and then mature MKS, thus providing an in vitro experimental tool to dissect the cellular and molecular basis of megakaryocytopoiesis. 6 1995 by The American Society of Hematology.
in vivo and in vitro a stimulatory activity restricted to the MK lineage21-26; ie, its function is similar to that postulated for thrombopoietin and possibly MK-CSF. The human mplL stimulates HPCs to generate MK colonies in semisolid medium and to produce a progeny containing 37% to 41% MKS in liquid cult~re.'~ Human MKS represent 0.03% of total bone marrow (BM) cells and 0.001% of PB cells.27 Studies on megakaryocytopoiesis have been hampered by lack of relatively pure, abundant MK populations. In an attempt to overcome this limitation, BM MKS', ' were partially purified by density gradients?' identified with specific monoclonal antibodies (MoAbs)?' and analyzed by immunofluorescence for the expression of lineage-specific genes3 ' We describe here a serum-free liquid culture for purified PB HPCs, which allows proliferation and gradual differentiatiodmaturation of a highly purified or pure MK progeny. 
MATERIALS AND METHODS

Recombinant Human HGFs and Medium
Adult PB and BM HPC Purification
Adult PB and BM were obtained from 20-to 40-year-old healthy male donors after informed consent. PB HPCs were purified from the buffy-coat by a three-step procedure according to a slight modification" of the method described in Gabbianelli et al." Particularly, the potentiated step 111 (Step IIIP) involves negative selection of low-density cells with an anti-T-, anti-B-, and anti-natural killerlymphocyte; anti-monocyte; and anti-granulocyte MoAb cocktail supplemented with anti-CD45, anti-CD1 la, and anti-CD71 MoAbs (Becton Dickinson, Mountain View, CA).
BM light density cells were isolated by centrifugation on a Ficoll gradient. HPCs were purified by cell sorting after double-labeling with fluorescein isothiocyanate-labeled, anti-CD34 MoAb and phycoerythrin-labeled anti-CD38 MOA^.^^ CD34+/CD38b"gh' and CD34+/CD38"d'" fractions were isolated and grown in liquid suspension culture as outlined below.
HPC Liquid Suspension Culture
Purified HPCs either from PB or BM (4 X lo4 celldml) were grown in FCS-liquid culture34; thus, Iscove's modified Dulbecco's medium was supplemented with bovine serum albumin (10 mg/mL), pure human transfenin (0.7 mg/mL), human low-density lipoprotein (40 pg ImL), insulin (10 
MK Characterization
Morphological and immunoperoxidase analysis. Cells cytocentrifuged onto glass slides were stained with May-GrUnwald Giemsa or labeled with MoAbs (CD61, CD4la, CD4lb, CD42b, and CD62; Becton Dickinson and Unipath, Milan, Italy), were treated with S M
Universal antimouse kit (Sigma Diagnostics, St
Louis, MO), and then were identified by morphology or immunoperoxidase analysis, respectively.
Membrane phenotype. MoAbs to CD34, CD62 (Becton Dickinson) conjugated with phycoerythrin and MoAbs to CD34, CD42b, CD61 (Becton Dickinson), CD4la (Serotec, Oxford, UK) conjugated with fluorescein isothiocyanate were used. For double-fluorescence analysis, 1 X 104 cells were incubated for 60 minutes at 4°C in the presence of an appropriate Ab dilution, were washed 3 times with cold phosphate-buffered saline containing 2 m@& bovine serum albumin, were resuspended in 0.2 mL phosphate-buffered saline/ formaldehyde, and were analyzed by FACScan (Lysis II program;
Becton-Dickinson).
In situ hybridization. In situ hybridization on MK-enriched cells was slightly modified from Car& et Briefly, we used a 49-mer oligonucleotide as a probe complementary to the 3018-through 3067-bp sequence of the von Willebrand factor (vWF) ~IRNA,'~ which was labeled with [ Y~~S ] deoxyadenosine triphosphate (dATp, New England Nuclear, Boston, MA) at the 5' end by T4 polynucleotide kinase.37 The cells, cytospun on gelatin-coated slides, were fixed, prehybridized, and hybridized as in Car& et except for the hybridization at 37°C. Washes were performed at room temperature for 60 minutes to a stringency of 1 X saline sodium citrate. The slides were dipped in NTBl emulsion (Eastman-Kodak, Rochester, N Y ) and were exposed at 4°C for 15 days in a light-proof box. Slides were developed in D-l9 (Eastman-Kodak), were fixed, and were stained with May-Griinwald Giemsa for microscopic analysis.
IL-6 and GM-CSF Assay in Culture Supernatant
L -6 and GM-CSF concentrations in the Supernatants of MK cultures were evaluated by sensitive and specific immunoassays (R&D For personal use only. on October 30, 2017. by guest www.bloodjournal.org From Systems, British Biotechnology, Cowly, Oxford, UK). Detection thresholds were 0.3 pg/mL and 2 pg/mL for L-6 and GM-CSF, respectively.
In addition to the controls performed by the suppliers, further controls were performed to determine assay specificity (ie, absence of cross-reactivity for each immunoassay against a large panel of recombinant cytokinedproteins). Each cytokine level represents the mean level observed in three separate determinations.
RESULTS
Purified PB
Step IIIP cells are -90% CD34+ and comprise 81.5% ? 1.2% HPCs (mean ? SEM values), as evaluated in 12 separate experiments assaying the number of BFU-E, CFU-GM, and CFU-GEMM colonies in methylcellulose culture treated with KL (100 ng/mL), IL-3 (100 U), GM-CSF (10 ng), and Epo (3 U)." The HFC clonogenetic assay has been recently optimized by adding to the standard HGFs (KL, L-3, GM-CSF, and Epo) saturating dosages of recombinant G-CSF (500 U/mL), M-CSF (250 U), and FLT3 ligand (100 ng). In a further series of 13 consecutive purification experiments, the HPC frequency increased to 90.3% ? 2.1% when using the optimized assay, as compared with 80.3% ? 3.2% with the standard HGF stimulus.
In a first series of experiments, 4 X IO4
Step IIIP cells were cultured in liquid suspension with four different combinations of early-acting HGFs: IL-3 (0.01 U/mL) + KL (10 ng); IL-3 + KL + IL-6 (10 ng); IL-3 + KL + IL-11 (10 ng); and IL-3 + KL + IL-6 + IL-11. The optimal concentration of each cytokine had been previously determined by dose-response experiments (data not shown). Cell growth was similar for all four different cytokine cocktails (Fig la,  left panel) . After 10 to 12 days of culture, morphological analysis indicated the presence of 20% to 42% MKS (mean values) in these different culture conditions (Fig la, right panel). The IL-3 + KL + IL-6 2 IL-l1 combinations allowed optimal MK growth (38% to 42%).
A detailed cellular analysis was performed for the IL-3 + KL + IL-6 cocktail. Morphology results are shown in Fig   l b (left panel) . At day 7, MKS represented 5% of total cells, blasts represented 40%, and early granulopoietic cells represented 55%. On day 12, 39% of cells were MKS, whereas the remaining cells largely pertained to the neutrophilic lineage. A representative May-Griinwald Giemsa staining of cytocentrifuged cells is shown in Fig IC (A and B) .
The membrane phenotype of the cells treated with antiplatelet MoAbs (CD61, CD62, and CD4la) and analyzed by flow cytometry from day 0 to day 14 of culture is shown in Fig l b (right panel) . In particular, 16% of the cells (mean value) were CD61+ at day 0. Double-immunofluorescence analysis indicated that virtually all CD61 + cells were CD34' (see also below). At days 9 and 12, the frequency of CD61+ cells showed a gradual increase, which paralleled that of MKS.
The expression of CD61, CD62, CD4la, CD4lb, and CD42b was analyzed by immunoperoxidase staining at days 10 to 12 of culture ( Table 1 and data not shown). The results indicated the presence of these specific markers on the majority of mature polynucleated MKS, as well as on putative mononuclear megakaryocytic precursor cells (immunoperoxidase anti-CD61 MoAb results are reported in Fig IC, C  through F) .
In a second series of Step IIIP cell liquid-phase cultures (Fig 2) , we observed that (1) the IL-3, IL-6, and KL combination again generated 40% MKS at day 12; (2) further addition of mplL did not modify the growth curve but markedly increased the MK percentage from 40% to 80%; and (3) mplL alone induced only a moderate cell proliferation, but resulted in a virtually pure MK progeny (97% to 99%), as evaluated by morphology.
Further studies were performed to characterize the mplLsupplemented culture systems. Because addition of mplL alone induced generation of a virtually "pure" MK progeny, we used this culture system to morphologically analyze the growing megakaryocytic cells at sequential stages of differentiatiodmaturation (representative results in Fig 3a; see also below and Fig 3c, left top panel) . At day 0, freshly purified Step IIIP cells are essentially composed of small undifferentiated blasts. At day 5, most cells are larger and mononuclear, whereas a small percentage (-10%) is binuclear. At this stage the cells represent putative MK precursors, which are morphologically different from undifferentiated blasts on cytospin preparations. Indeed, the putative MK precursors are larger and have an oval or round shape with a large and pale cytoplasm showing a "white" perinuclear area, probably corresponding to the Golgi, and a peripheral blue area. In contrast, undifferentiated blasts are smaller, have a round shape with a small, thin blue cytoplasm. At day 7, most cells show two nuclei, and the chromatin is more dense. At day 9, the majority of cells reached the polyploid stage with two, four, or more nuclei. Finally, at day 12, the large majority of MKS were highly polyploid and showed platelet formation. A significant proportion of polynucleated MKS showed long cytoplasmic processes emanating from cell bodies (Fig 3b) and contained innumerable granules scattered throughout the cytoplasm that stain pink, magenta, and blue.
These morphological observations correlate with the membrane phenotype analysis by double-labeling with anti-CD34 and anti-CD61 or anti-CD42b MoAbs, which recognize an early or late MK-specific marker, respectively (representative results in Fig 3c; virtually identical results were obtained in two other independent experiments). At day 0, 10% to 20% of quiescent CD34' cells express CD61 but not CD42b. At day 5 , a significant number (61 %) of CD34' cells coexpress CD61; they probably represent the putative MK precursors described above. CD42b was also coexpressed at day 5 but in a lower percentage of CD34' cells (27%). In late cultures (days 9 to 12), the cells progressively became CD34-and CD61+/CD42b+.
Finally, we show a comparative analysis of morphology and membrane antigen kinetics in cultures supplemented with mplL alone or in combination with IL-3, KL, and IL-6 (representative results in Fig 3d; virtually identical results were obtained in two other independent experiments). Morphology analysis (Fig 3d, left panels) shows the relative number of mature polynucleated MKS in a population composed of both MKS and MK precursors (the precursors were identified as described above). The results in mplL-treated culture (Fig 3d, left top panel) have been described above.
In the mplL + early HGF culture (Fig 3d, left bottom .
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although the final MK purity was lower (80%) and the maturation process was slightly delayed. In both culture conditions, CD34 was expressed at a high level from days 0 to 5 and progressively decreased thereafter with a similar pattern (Fig 3d, right panels) . Interestingly, the MK-specific membrane markers CD4la, CD42b, CD61, and CD62 were progressively induced in both culture systems but showed a more rapid increase after treatment with mplL alone as compared with that of mplL + early HGFs (Fig 3d, right panels) .
Finally, we investigated the mRNA expression of the MK specific vWF by in situ hybridization. Figure 3e shows representative results at day 12 in early HGF (top panel) or early HGF+mplL (bottom panel) cultures. Specific hybridized areas were observed in all mature MKS but not in contaminant cells, which were essentially neutrophils and rare macrophages. Here again, mononuclear cells not morphologically recognizable as polynucleated mature MKS but positive for this transcript were identified as MK precursors on the basis of the above-mentioned morphology analysis in "pure" megakaqocytic culture. Indeed, the percentage of vWF+ cells (80%) detected by in situ hybridization in the presence of mplL + grown in the presence of mplL to release IL-6 and GM-CSF, which affect MK proliferation and differentiation (see Introduction). Low levels of both cytokines were detected in MK culture Supernatants, particularly at days 9 to 12 of culture (Table 2) . A final set of experiments was performed to comparatively evaluate the effect of mplL on BM HPCs, which were purified according to their positivity for CD34 and subdivided on the basis of high (CD34+/CD38hi) and low (CD34+/CD38I0) CD38 expression. In a representative experiment, CD34+/ 38hi and CD34+/38I0 cells assayed in semisolid culture supplemented with KL/IL-3/GM-CSF/Epo comprised 34% and 20% of the HPCs (BFU-E + CFU-GM + CFU-GEMM), respectively, thus in line with previous results.33 Both cell populations were grown in liquid suspension culture in the presence of mplL (Fig 4) . CD34+/CD38h cells showed a growth lower than that observed for Step IIIP PB HPCs and generated a progeny composed of 62% MKS and 38% neutrophils and macrophages; CD34+/CD38I0 cells showed no proliferation and generated a progeny composed of a large majority of MKS (93%) and few neutrophils (7%).
DISCUSSION
The discrete molecular events underlying early hematopoiesis are still poorly understood, primarily because of the For personal use only. on October 30, 2017 . by guest www.bloodjournal.org From The values shown are the mean i SEM from three separate experiments. Each sample was assayed in triplicate.
extreme rarity of HPCs and HSCs in human BM and
In an attempt to overcome this limitation, we have developed methodology for HPC purification and unilineage proliferatioddifferentiation. The recently improved purification method allows both stringent purification and abundant recovery of HPCs (CFU-GEMM, BFU-E, CFU-GM) from adult PB.3L*38.41 The purified Step IIIP HPCs represent a homogeneous population of highly undifferentiated Furthermore, we have developed an FCS-liquid suspension culture for gradual unilineage differentiation of Step IIIP HPCs along the erythroid4' or granulopoietic-neutrophili~~~~~ lineage by addition of low-level multilineage HGFs (IL-3 and GM-CSF) combined with saturating amounts of a unilineage HGF (Epo or G-CSF, respectively). Recently, unilineage monocytic differentiation of HPCs was observed in FCS+ liquid suspension cultures treated with flt3 ligand and M-CSF.'" These culture systems allow sequential collection and molecular analysis of discrete subsets of HPCs and hematopoietic precursors at a homogeneous stage of differentiatiodmaturation along a specific lineage.41*42.45- 47 We report an FCS-liquid culture system for unilineage megakaryocytic growth of Step IIIP HPCs. In the first week of culture, HPCs apparently differentiate along the megakaryocytic lineage, as shown by (1) gradual decrease of CD34+ cells and blasts and (2) progressive increase of CD34+ cells double-labeled for CD61 and other megakaryocytic membrane markers. The second week is characterized by the proliferatioddifferentiation of megakaryocytic precursors; this is indicated by gradual appearance of maturing MKS (from the binuclear to more than 8-nuclei stage) coupled with increasing expression of lineage-specific membrane (CD4la, CD42b, CD61, and CD62) and cytoplasmic (vWF) markers and a further decrease of CD34+ cell frequency.
p~.32,38-40 HpCs,31.38.41.42 as compared with BM primitive H P C S .~~.~
3733
At late days of culture (ie, from days 9 to 121, we observed large polynucleated MKS, which contain innumerable granules scattered throughout the cytoplasm. A portion of these MKS shows long cytoplasmic processes emanating from their cell bodies. These morphological features are consistent with the proplatelet definiti~n~~.~' and are in line with the notion that proplatelets may represent the structural precursors to platelet^.^' The end-stage maturation of MKS is further supported by the high PF4 level (> 100 IU/mL) in day-12 culture supernatant (data not shown).
MK purity and yield markedly differ in the various culture conditions described here. As mentioned above, HPC treatment with multilineage HGFs (lowdose IL-3 and GM-CSF) combined with unilineage HGF (saturating amounts of Epo or G-CSF) allows the selective growth of erythroid or granulopoietic cells of neutrophilic type, respe~tively.4'~~~'~ Along these lines, the present studies indicate that combined addition of earlyacting HGFs (L-3, KL, and IL-6) and mplL provides optimal megakaryocytic growth, as evaluated in terms of MK purity (80% MK cells) and yield (14-fold amplification over initial cell number). IL-3 and GM-CSF induce HPC proliferation and partial differentiation to mature In our culture system, GM-CSF is not supplemented, whereas IL-3 is added at low concentration. This optimal MK growth is not associated with extensive proliferation of granulopoietic cells on combined mplL addition. Interestingly, saturating dosages of IL-6 and KL, while largely ineffective by themselves, potentiate the IL-3 action on MK growth.
As compared with the early HGFs + mplL culture system,
(1) addition of mplL alone generated a virtually pure (97% to 99%) MK progeny but induced a lower amplification of cell number (3.5-to 4-fold increase), and (2) addition of early HGFs without mplL caused extensive MK proliferation but was associated with prevailing growth of granulocytic cells. Stringently optimized FCS-culture conditions may further improve the amplification of megakaryocytic cell number; eg, a recent culture series with recombinant mplL alone showed a mean 10-fold increase.
The present culture system yielding highly purified or pure MKS through sequential stages of cell differentiation and maturation provides insight into early megakaryocytopoiesis. CD61, a specific MK marker,53354 is expressed on a small but significant proportion (10% to 20%) of freshly purified CD34+ HPC cells. This CD34+/CD61+ subset may represent HPCs potentially committed to MK differentiation. In line with this hypothesis, HPC induction to megakaryocytic differentiation is coupled with gradual amplification of the CD34+/61+ cell population, which is followed by progressive expression of CD61 and loss of CD34 at late culture MK-specific antigens (CD4la, CD42b, CD61, and CD62) are more rapidly induced in cultures supplemented with mplL alone than in those supplemented with both mplL and early HGFs. This pattern is consistent with the observation that mplL induces selective MK differentiation, and further addition of early HGFs also causes a marked amplification of megakaryocytic cell number. These results suggest that (1) mplL induces the differentiation of MK-committed HPCs and (2) IL-3, KL, and IL-6 trigger extensive growth of HPCs, which are then channeled by mplL into the megakaryocytic differentiation pathway.
We suggest that in day-5 mpll-stimulated cultures the prevailing population of large mononuclear cells may represent MK precursors with a CD34+/CD61f immunophenotype. These MK precursors were also previously observed in liquid suspension cultures of BM CD34' cells stimulated Previous studies have shown that normal human MKS are capable of synthesizing and secreting cytokines, notably IL-6'' and GM-CSF.'5 We attempted to verify whether MKS originated in mplL-stimulated cultures of Step IlIP cells show this property. Analysis of IL-6 and GM-CSF levels in culture supernatants showed low but significant levels of both IL-6 and GM-CSF from day 5 onward, thus suggesting that the capacity to secrete these two cytokines is acquired during early MK differentiation. Accordingly, previous studies showed that both megakaryoblasts and mature MKS synthesize and secrete IL-6 and GM-CSF." Autocrine IL-6 and GM-CSF secretion by MKS may synergize with exogenous mplL to sustain in vitro proliferation and differentiation of MK precursors.
In parallel comparative studies, we have evaluated the effect of mplL on the growth and differentiation of purified 
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CD34+/38~ and CD34+/38'" BM cells. Previous studies have shown that CD34+/38" cells are highly enriched for early HPCs, whereas CD34+/38" cells are associated with lineage committment and contain a lower number of early H P C S .~~"~ Both cell populations generate MKS in the presence of mplL but show differential features from mplL-stimulated PB Step IIIP cells. (1) CD34+/38I0 cells generate a cell progeny almost exclusively composed by MKS but do not proliferate, and (2) CD34+/38" cells proliferate less than Step IIIP cells and are contaminated by a significant proportion (38%) of granulomonocytic cells. These differences may, at least in part, relate to the higher HPC frequency in PB Step IIIP cells (80%) as compared with that in BM CD34+/CD3810/hi cells (20% to 30%).
The methodology described here for megakaryocytic PB HPC culture compares favorably with previous proceculture studies, PB or BM HPCs treated with HGFs other than mplL generated a cell population with low MK frequency (~1 0 % ) ,~.~~ whereas PB HPCs treated with mplL alone produced a progeny containing 37% to 41% M K s .~~ Both MK purity values are markedly lower than those reported here for the corresponding culture conditions (ie, 97%
to 99% or 80% MKS on mplL or mplL + early HGF treatment and 38% to 42% MKS after early HGF addition). The improved purity possibly relates to the stringent HPC purification applied here. More important, we report for the first time a high MK yield in the mplL + early HGF culture.
In conclusion, this HPC differentiation culture system promotes the growth of a relatively large number of highly purified or virtually pure megakaryocytic precursors and then mature MKS, thus providing an in vitro experimental tool to dissect the cellular and molecular basis of megakaryocytopoiesis.
dures52.57.58 in terms of MK purity and yield. In former liquid For personal use only. on October 30, 2017 . by guest www.bloodjournal.org From
